These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 33289178)
61. Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction. Lu J; Goldsmith MR; Grulke CM; Chang DT; Brooks RD; Leonard JA; Phillips MB; Hypes ED; Fair MJ; Tornero-Velez R; Johnson J; Dary CC; Tan YM PLoS Comput Biol; 2016 Feb; 12(2):e1004495. PubMed ID: 26871706 [TBL] [Abstract][Full Text] [Related]
62. Physiological "constants" for PBPK models for pregnancy. Young JF; Branham WS; Sheehan DM; Baker ME; Wosilait WD; Luecke RH J Toxicol Environ Health; 1997 Dec; 52(5):385-401. PubMed ID: 9388532 [TBL] [Abstract][Full Text] [Related]
63. Physiologically based pharmacokinetic (PBPK) modeling of everolimus (RAD001) in rats involving non-linear tissue uptake. Laplanche R; Meno-Tetang GM; Kawai R J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):373-400. PubMed ID: 17431753 [TBL] [Abstract][Full Text] [Related]
64. Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview. Jia Q; He Q; Yao L; Li M; Lin J; Tang Z; Zhu X; Xiang X Molecules; 2022 Dec; 27(24):. PubMed ID: 36557804 [TBL] [Abstract][Full Text] [Related]
65. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations. Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198 [TBL] [Abstract][Full Text] [Related]
66. Zhang CX; Arnold SLM Drug Metab Dispos; 2023 Sep; ():. PubMed ID: 37714715 [TBL] [Abstract][Full Text] [Related]
67. Ionophore coccidiostats - disposition kinetics in laying hens and residues transfer to eggs. Bello A; Henri J; Viel A; Mochel JP; Poźniak B Poult Sci; 2023 Jan; 102(1):102280. PubMed ID: 36410065 [TBL] [Abstract][Full Text] [Related]
68. Development and application of a population physiologically based pharmacokinetic model for florfenicol and its metabolite florfenicol amine in cattle. Yang F; Lin Z; Riviere JE; Baynes RE Food Chem Toxicol; 2019 Apr; 126():285-294. PubMed ID: 30825586 [TBL] [Abstract][Full Text] [Related]
69. An introduction to physiologically-based pharmacokinetic models. Upton RN; Foster DJ; Abuhelwa AY Paediatr Anaesth; 2016 Nov; 26(11):1036-1046. PubMed ID: 27550716 [TBL] [Abstract][Full Text] [Related]
70. An approach for incorporating tissue composition data into physiologically based pharmacokinetic models. Pelekis M; Poulin P; Krishnan K Toxicol Ind Health; 1995; 11(5):511-22. PubMed ID: 8677516 [TBL] [Abstract][Full Text] [Related]
71. Bayesian population physiologically-based pharmacokinetic model for robustness evaluation of withdrawal time in tilapia aquaculture administrated to florfenicol. Lin HC; Chen WY Ecotoxicol Environ Saf; 2021 Mar; 210():111867. PubMed ID: 33387907 [TBL] [Abstract][Full Text] [Related]
72. A Whole-Body Physiologically Based Pharmacokinetic Model for Alpha Particle Emitting Bismuth in Rats. Zaid NRR; Kletting P; Winter G; Beer AJ; Glatting G Cancer Biother Radiopharm; 2022 Feb; 37(1):41-46. PubMed ID: 34185608 [No Abstract] [Full Text] [Related]
73. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation. Ellison CA Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539 [TBL] [Abstract][Full Text] [Related]
74. Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Cardiac Output and Its Distribution to Different Organs during Development. Abduljalil K; Pan X; Clayton R; Johnson TN; Jamei M Clin Pharmacokinet; 2021 Jun; 60(6):741-757. PubMed ID: 33486719 [TBL] [Abstract][Full Text] [Related]
75. Use of a Monte Carlo analysis within a physiologically based pharmacokinetic model to predict doxycycline residue withdrawal time in edible tissues in swine. Yang F; Liu HW; Li M; Ding HZ; Huang XH; Zeng ZL Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(1):73-84. PubMed ID: 22059524 [TBL] [Abstract][Full Text] [Related]
76. Physiologically based pharmacokinetic modeling of POPs in Greenlanders. Sonne C; Gustavson K; Rigét FF; Dietz R; Krüger T; Bonefeld-Jørgensen EC Environ Int; 2014 Mar; 64():91-7. PubMed ID: 24382481 [TBL] [Abstract][Full Text] [Related]
77. A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of Siebinga H; de Wit-van der Veen BJ; Beijnen JH; Stokkel MPM; Dorlo TPC; Huitema ADR; Hendrikx JJMA EJNMMI Res; 2021 Aug; 11(1):73. PubMed ID: 34398356 [TBL] [Abstract][Full Text] [Related]
78. Physiologically Based Pharmacokinetic Modeling of Therapeutic Proteins. Wong H; Chow TW J Pharm Sci; 2017 Sep; 106(9):2270-2275. PubMed ID: 28392453 [TBL] [Abstract][Full Text] [Related]
79. Probabilistic Physiologically Based Pharmacokinetic Model for Penicillin G in Milk From Dairy Cows Following Intramammary or Intramuscular Administrations. Li M; Gehring R; Riviere JE; Lin Z Toxicol Sci; 2018 Jul; 164(1):85-100. PubMed ID: 29945226 [TBL] [Abstract][Full Text] [Related]
80. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats. Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]